A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy

Yelda A Leal1, Alejandro Gómez, Armando Madrazo-de la Garza

  • 1Unidad de Investigación Médica, Unidad Médica de Alta Especialidad del Centro Médico Nacional "Ignacio García Téllez" IMSS Mérida, Yucatán. yelda_leal@hotmail.com

Insights

A primary Helicobacter pylori infection offers no significant protection against reinfection in children. This study found similar infection rates in both previously uninfected and eradicated children over two years.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Immunology

Background:

  • Helicobacter pylori infection is a common childhood infection globally.
  • The protective effect of a primary H. pylori infection against subsequent reinfection in children remains unclear.
  • Understanding reinfection dynamics is crucial for managing this prevalent pathogen.

Purpose of the Study:

  • To investigate the protective immunity conferred by a primary Helicobacter pylori infection against reinfection in pediatric populations.
  • To compare the incidence of new H. pylori infections in children with no prior infection versus those who were successfully treated.

Main Methods:

  • A 2-year follow-up study involving 120 children, divided into a primo-infection cohort (n=80) and a reinfection cohort (n=40).
  • Urea breath tests (UBT) were administered every 3-6 months to detect H. pylori acquisition.
  • Statistical analysis, including chi-squared tests and survival curves, compared infection and reinfection rates and evaluated risk factors.

Main Results:

  • No significant difference was observed in primo-infection rates (21.2%) versus reinfection rates (25%).
  • Most primo-infections occurred within the first year, while reinfections were more common in the second year.
  • The majority of H. pylori infections in both cohorts were transient, with similar risk factors identified.

Conclusions:

  • A prior Helicobacter pylori infection does not provide substantial protection against reinfection in the studied pediatric cohort.
  • The findings suggest that immunity following initial H. pylori infection may be short-lived or incomplete in children.
  • Further research is needed to elucidate the immunological mechanisms influencing H. pylori reinfection in children.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.